1Medizinische Klinik III, Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Adjuvant chemotherapy for high-grade soft-tissue sarcomas remains investigational. Current evidence suggests potential risks outweigh survival benefits, necessitating further clinical trials for high-risk patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: